News

26/06/2015

Stallergenes shareholders approve the project to combine the activities of the Group and Greer Laboratories

08/06/15
Stallergenes is pleased to see the mobile allergen exposure chamber at the 2015 EAACI congress, Barcelona

> Read more

[more]
21/04/15
Strong sales growth in Q1 2015 (up 7.5%) exceeding targets

Positive performance in all geographic regions

Significant growth in the...

[more]

Follow us on :

STALLERGENES, A GLOBAL ALLERGY PLAYER


Stallergenes is a global pharmaceutical company with leading innovation, provider of allergy solutions all around the world. 

Stallergenes’ comprehensive approach to allergic diseases includes a complete portfolio combining diagnosis products and treatments and a new generation of allergen immunotherapy treatments.